| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0023 | 0.9 |